“Ms. James’ leadership in pharmaceutical development services, as well as her experience in building effective partnerships, will support the transformation of our current team into a scalable, high-growth organization.”
WESTMINSTER, Colo. (PRWEB) July 18, 2019
Flagship Biosciences, the advanced tissue data services company, today announced the addition of Meredith James, HT, PMP, to its executive team as Vice President of Operations. Ms. James brings a wealth of experience gained in over 20 years in drug development. In her new role, Ms. James is responsible for ensuring on-time delivery of all projects by overseeing the overall day-to-day operations of Flagship’s services. Her experience will support the continued delivery of the highest quality data to Flagship’s clients.
With a career that spans laboratory operations and clinical program and project management, Ms. James most recently led translational programs at Precision for Medicine. She previously held leadership positions at PPD Laboratories and Quintiles (now part of IQVIA) where she helped to develop, manage, and organize processes and vendor relationships. Ms. James’ additional years in laboratory, IT, and account and project management make her uniquely suited to the new role.
“I am pleased to have Ms. James join our diverse and distinguished team here at Flagship,” said Trevor Johnson, Flagship Biosciences CEO. “Ms. James’ leadership in pharmaceutical development services, as well as her experience in building effective partnerships, will support the transformation of our current team into a scalable, high-growth organization."
“It is a very exciting time to join the Flagship Biosciences team,” said Ms. James. “I am thrilled to be able to collaborate within what is already an exceptional operations department. I look forward to growing and scaling the team to meet the demands of the market.”
About Flagship Biosciences
Flagship Biosciences, Inc. is an advanced tissue analysis services company delivering science-based innovation for improved drug development. The company offers a full range of tissue analysis services using its award-winning technology to deliver breakthrough contextual data supported by a team of experienced pathologists and scientists. It caters to pharmaceutical, biotechnology, and clinical diagnostic companies. Flagship Biosciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado. http://www.flagshipbio.com